KennethN.M.SumidaMDMS

Oncology • Honolulu, HI

Hematologic Oncology

Associate Professor of Medicine, University of Hawaii

Join to view full profile

Dr. Sumida is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sumida's full profile

Already have an account?

Office
321 N Kuakini St
412
Honolulu, HI 96817
Phone+1 808-531-8521

Fax+1 808-539-9337

Education & Training

Scripps Clinic/Scripps Green HospitalFellowship, Hematology and Medical Oncology, 1986 - 1989
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1982 - 1986
University of Hawaii, John A. Burns School of MedicineClass of 1982

Certifications & Licensure

HI State Medical License 1989 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery Start of enrollment: 2013 Aug 01
Active, not recruiting
Not Applicable
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Jan 15
Active, not recruiting
Phase 3
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Active, not recruiting
Phase 3
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2019 Jul 25
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Uncommon Presentation of IgM Monoclonal Gammopathy of Undetermined Significance (MGUS) and Anti-Myelin-Associated Glycoprotein (MAG)-Associated Demyelinating Periphera...
Manasawee Tanariyakul, Kensuke Takaoka, Toshiaki Takahashi, Jonathan Estaris, Kenneth Sumida
Cureus. 2024-06-01
2 citations
Overcoming racial disparities in cancer clinical trial enrollment of Asians and Native Hawaiians.
Jared D Acoba, Ken Sumida, Jeffrey Berenberg
Contemporary Clinical Trials Communications. 2022-08-01
10 citations
Racial and Ethnic Disparities in Rates of Invasive Second Breast Cancer Among Women With Ductal Carcinoma In Situ in Hawai'i.
Kekoa Taparra, Jami Fukui, Jeffrey Killeen, Kenneth Sumida, Lenora W. M. Loo
JAMA Network Open. 2021-10-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member
American College of Physicians - ACP
Fellow